Last reviewed · How we verify
Placebo (twice daily)
Placebo produces no pharmacological effect and serves as an inert control in clinical trials.
At a glance
| Generic name | Placebo (twice daily) |
|---|---|
| Sponsor | Prime Gene Therapeutics Co., Ltd. |
| Modality | Small molecule |
| Phase | Phase 3 |
Mechanism of action
Placebo is a non-active substance administered in clinical trials to establish baseline efficacy and safety profiles through comparison with active drug arms. Any observed effects are attributable to natural disease progression, regression to the mean, or the placebo effect (psychological/expectation-driven response). Placebo is essential for blinded trial design to isolate true drug efficacy from bias.
Approved indications
Common side effects
Key clinical trials
- A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome (PHASE3)
- The Intervention of Obesity in Children With Prader-Willi Syndrome Using Prebiotics and Probiotics (NA)
- Effectiveness of Combined Super Inductive System (SIS) Therapy With Therapeutic Exercise and Health Education in Lateral Elbow Tendinopathy (NA)
- Study of Oral Idebenone to Treat Non-Alcoholic Steatohepatitis (PHASE1, PHASE2)
- The Impact of Factor Xa Inhibition on Thrombosis, Platelet Activation, and Endothelial Function in Peripheral Artery Disease (PHASE4)
- A Study of the Efficacy and Safety of Danicamtiv in Participants With Symptomatic Genetic and Familial Dilated Cardiomyopathy (PHASE2, PHASE3)
- A Study of Doxycycline to Treat Chlamydial Infection (PHASE4)
- Belimumab and Rituximab Combination Therapy for the Treatment of Diffuse Cutaneous Systemic Sclerosis (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Placebo (twice daily) CI brief — competitive landscape report
- Placebo (twice daily) updates RSS · CI watch RSS
- Prime Gene Therapeutics Co., Ltd. portfolio CI